The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region
Combined maintenance therapy with anti-PD-1 antibodies and capecitabine may be a feasible treatment strategy for mNPC patients.
Authors
- Zhuo-Ying Luo (ORCID: https://orcid.org/0000-0003-2220-1850)
- Ze‐Jiang Zhan (ORCID: https://orcid.org/0000-0003-1609-6919)
- Xing Lv (ORCID: https://orcid.org/0000-0003-3125-6853)
- Wei Xue-hua
- Wei‐Xiong Xia (ORCID: https://orcid.org/0000-0002-2828-5963)
- Yue Xia
- Jin‐Ling Duan (ORCID: https://orcid.org/0000-0002-8297-3003)
- Xun Cao (ORCID: https://orcid.org/0000-0003-1617-1501)
- Xi Chen (ORCID: https://orcid.org/0000-0002-8259-9509)
- Ying Deng (ORCID: https://orcid.org/0000-0003-2483-4707)
- Yingying Huang (ORCID: https://orcid.org/0000-0003-4837-731X)
- Haoyang Huang
- Jiayu Zhou (ORCID: https://orcid.org/0000-0001-7164-0943)
- Liang‐Ru Ke
- Hu Liang
- Yuping Zhao
- Chixiong Liang
Institutions
- Sun Yat-sen University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- State Key Laboratory of Oncology in South China
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Clinical & Translational Immunology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1002/cti2.70043
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province